GURUFOCUS.COM » STOCK LIST » Financial Services » Credit Services » Ventana Biotech Inc (OTCPK:VNTA) » Definitions » Equity-to-Asset

VNTA (Ventana Biotech) Equity-to-Asset : 0.00 (As of . 20)


View and export this data going back to 2008. Start your Free Trial

What is Ventana Biotech Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Ventana Biotech's Total Stockholders Equity for the quarter that ended in . 20 was $0.00 Mil. Ventana Biotech's Total Assets for the quarter that ended in . 20 was $0.00 Mil.

The historical rank and industry rank for Ventana Biotech's Equity-to-Asset or its related term are showing as below:

VNTA's Equity-to-Asset is not ranked *
in the Credit Services industry.
Industry Median: 0.37
* Ranked among companies with meaningful Equity-to-Asset only.

Ventana Biotech Equity-to-Asset Historical Data

The historical data trend for Ventana Biotech's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ventana Biotech Equity-to-Asset Chart

Ventana Biotech Annual Data
Trend
Equity-to-Asset

Ventana Biotech Semi-Annual Data
Equity-to-Asset

Competitive Comparison of Ventana Biotech's Equity-to-Asset

For the Credit Services subindustry, Ventana Biotech's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ventana Biotech's Equity-to-Asset Distribution in the Credit Services Industry

For the Credit Services industry and Financial Services sector, Ventana Biotech's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Ventana Biotech's Equity-to-Asset falls into.



Ventana Biotech Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Ventana Biotech's Equity to Asset Ratio for the fiscal year that ended in . 20 is calculated as

Equity to Asset (A: . 20 )=Total Stockholders Equity/Total Assets
=/
=

Ventana Biotech's Equity to Asset Ratio for the quarter that ended in . 20 is calculated as

Equity to Asset (Q: . 20 )=Total Stockholders Equity/Total Assets
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ventana Biotech  (OTCPK:VNTA) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Ventana Biotech Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Ventana Biotech's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Ventana Biotech Business Description

Traded in Other Exchanges
N/A
Address
1660 South Albion Street, Suite 1007, Denver, CO, USA, 80222
Ventana Biotech Inc is a development stage company providing alternative financing in the capacity of a broker for those commercial borrowers in need of non-bank financing.